PAM-Dependent Target DNA Recognition and Cleavage by C2c1 CRISPR-Cas Endonuclease
Overview
Affiliations
C2c1 is a newly identified guide RNA-mediated type V-B CRISPR-Cas endonuclease that site-specifically targets and cleaves both strands of target DNA. We have determined crystal structures of Alicyclobacillus acidoterrestris C2c1 (AacC2c1) bound to sgRNA as a binary complex and to target DNAs as ternary complexes, thereby capturing catalytically competent conformations of AacC2c1 with both target and non-target DNA strands independently positioned within a single RuvC catalytic pocket. Moreover, C2c1-mediated cleavage results in a staggered seven-nucleotide break of target DNA. crRNA adopts a pre-ordered five-nucleotide A-form seed sequence in the binary complex, with release of an inserted tryptophan, facilitating zippering up of 20-bp guide RNA:target DNA heteroduplex on ternary complex formation. Notably, the PAM-interacting cleft adopts a "locked" conformation on ternary complex formation. Structural comparison of C2c1 ternary complexes with their Cas9 and Cpf1 counterparts highlights the diverse mechanisms adopted by these distinct CRISPR-Cas systems, thereby broadening and enhancing their applicability as genome editing tools.
Zheng W, Li H, Liu M, Wei Y, Liu B, Li Z Signal Transduct Target Ther. 2025; 10(1):66.
PMID: 39955288 PMC: 11830025. DOI: 10.1038/s41392-025-02147-5.
Cas12e orthologs evolve variable structural elements to facilitate dsDNA cleavage.
Li D, Zhang S, Lin S, Xing W, Yang Y, Zhu F Nat Commun. 2024; 15(1):10727.
PMID: 39737904 PMC: 11685505. DOI: 10.1038/s41467-024-54491-9.
DNA target binding-induced pre-crRNA processing in type II and V CRISPR-Cas systems.
Chen J, Lin X, Xiang W, Chen Y, Zhao Y, Huang L Nucleic Acids Res. 2024; 53(3).
PMID: 39676682 PMC: 11797020. DOI: 10.1093/nar/gkae1241.
CRISPR-based gene editing technology and its application in microbial engineering.
Wei J, Li Y Eng Microbiol. 2024; 3(4):100101.
PMID: 39628916 PMC: 11610974. DOI: 10.1016/j.engmic.2023.100101.
Structure and genome editing activity of the novel CRISPR-Cas12o1 effector.
Duan Z, Zhang X, Zhang J, Ji X, Liu R, Chen Y Cell Res. 2024; 35(2):145-148.
PMID: 39516663 PMC: 11770080. DOI: 10.1038/s41422-024-01050-y.